Anteris AGM 15 July 21

The Annual General Meeting of Anteris Technologies Ltd was held at 10:00 a.m. AEST on Thursday 15 July 2021.

Anteris Technologies 'sitting on a significantly large opportunity' as it moves into FDA studies

Anteris Technologies 'sitting on a significantly large opportunity' as it moves into FDA studies

Wayne Paterson from Anteris - Switzer Virtual Investor Day 2021

Recording of Anteris Presenting at the Switzer Small and Micro-Cap Virtual Investor Day

MST Access Australian Micro & Small Caps Conference 2021 - Anteris Technologies Limited

Anteris Technologies Ltd's (ASX:AVR) Wayne Paterson, CEO, presented at MST Access Micro & Small Caps Conference on Thursday, 17 June

Anteris Technologies CEO - Fortem Wealth - Quarterly Interview

CEO W. Paterson interviewed by Jacob Pritchard

MST Access - AVR Update Report May 21

Raising DurAVR valve's clinical profile

Heart Innovator Anteris Takes on Medical Device Giants

It has been a rocky corporate journey for the ASX-listed Anteris Technologies, but with its revolutionary heart technology Anteris has the ticker to be the next Aussie medical device giant.

Next Generation TAVR device will enable Lifetime management of Aortic Stenosis patients - EuroPCR 2021

Next Generation TAVR device will enable Lifetime management of Aortic Stenosis patients

Bioshares - Anteris Meets Catheter Milestone

Anteris Technologies Meets Catheter Milestone

Eureka Report - How Anteris Technologies got its credibility back

CEO Wayne Paterson (Anteris Technologies) is interviewed by Alan Kohler, Editor-in-Chief at Eureka Report

Q&A with StockPal - Anteris Technologies (ASX:AVR)

CEO W. Paterson interviewed by J. Sim, Editor-in-Chief & Co-Founder at StockPal.

Bioshares - Anteris Demonstrates ADAPT Process Outperforms Medtronic's AOA Process in Animal Study

Bioshares - Anteris Demonstrates ADAPT Process Outperforms Medtronic's AOA Process in Animal Study